Please ensure Javascript is enabled for purposes of website accessibility

Why Athenahealth, Inc. Shares Skyrocketed

By Sean Williams – Feb 7, 2014 at 1:41PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Athenahealth shares soar after handily surpassing Wall Street's earnings forecast. Can shares continue to rally or should you consider taking your gains?

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of athenahealth (ATHN), a cloud-based provider of practice management, electronic health records, and care coordination for medical practices around the country, skyrocketed as much as 26% after reporting better-than-expected fourth quarter earnings results.

So what: For the quarter, athenahealth delivered year-over-year revenue growth of a whopping 48% to $171.6 million as GAAP income more than doubled and adjusted EPS flew to $0.57. By comparison, Wall Street's consensus estimate had called for a profit of just $0.44 per share on $168.6 million in revenue. Excluding revenue generated from athenahealth's purchase of Epocrates, year-over-year organic growth totaled 28% to $149 million, and adjusted gross margin expanded 280 basis points to 66.2%.

Now what: While today's results were undoubtedly solid, I'm still not sold on athenahealth at these levels. On one hand, its growth rate is undeniably fast, and the push toward electronic and cloud-based practice management and care coordination is high among hospitals and medical clinics in an effort to streamline operations and save costs. The implementation of Obamacare should only further push clinics to seek out athenahealth's cloud-based management platforms.

On the other hand, this valuation is downright scary for anyone who has the slightest belief in value investing. At roughly 130 times forward estimates, a price-to-sales of nearly 12, and with costs soaring as the company spends heavily on R&D and marketing its product, it's difficult to see how investors are going to squeeze any more blood out of this turnip. That being said, I believe athenahealth is worth a watchlist add, but I personally fail to see how its share price can head any higher.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

The Motley Fool recommends Athenahealth. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Nearly 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

athenahealth, Inc. Stock Quote
athenahealth, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.